Compare Pfizer with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ORCHID PHARMA LTD - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ORCHID PHARMA LTD PFIZER/
ORCHID PHARMA LTD
 
P/E (TTM) x 35.9 -0.5 - View Chart
P/BV x 6.1 0.1 5,151.3% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 PFIZER   ORCHID PHARMA LTD
EQUITY SHARE DATA
    PFIZER
Mar-19
ORCHID PHARMA LTD
Sep-13
PFIZER/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs3,840194 1,979.4%   
Low Rs2,08035 5,942.9%   
Sales per share (Unadj.) Rs455.0276.5 164.6%  
Earnings per share (Unadj.) Rs93.8-79.2 -118.4%  
Cash flow per share (Unadj.) Rs109.4-43.5 -251.7%  
Dividends per share (Unadj.) Rs22.500-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs658.253.9 1,220.3%  
Shares outstanding (eoy) m45.7570.45 64.9%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x6.50.4 1,570.9%   
Avg P/E ratio x31.6-1.4 -2,183.5%  
P/CF ratio (eoy) x27.1-2.6 -1,026.9%  
Price / Book Value ratio x4.52.1 211.8%  
Dividend payout %24.00-   
Avg Mkt Cap Rs m135,4208,067 1,678.8%   
No. of employees `0002.62.8 94.0%   
Total wages/salary Rs m3,2382,527 128.2%   
Avg. sales/employee Rs Th7,911.46,956.1 113.7%   
Avg. wages/employee Rs Th1,230.9902.5 136.4%   
Avg. net profit/employee Rs Th1,630.7-1,993.0 -81.8%   
INCOME DATA
Net Sales Rs m20,81519,477 106.9%  
Other income Rs m1,674407 411.1%   
Total revenues Rs m22,48919,884 113.1%   
Gross profit Rs m5,7121,103 518.0%  
Depreciation Rs m7142,519 28.3%   
Interest Rs m735,227 1.4%   
Profit before tax Rs m6,599-6,236 -105.8%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m2,309-125 -1,843.9%   
Profit after tax Rs m4,291-5,580 -76.9%  
Gross profit margin %27.45.7 484.7%  
Effective tax rate %35.02.0 1,742.5%   
Net profit margin %20.6-28.7 -71.9%  
BALANCE SHEET DATA
Current assets Rs m27,16711,014 246.7%   
Current liabilities Rs m8,91732,060 27.8%   
Net working cap to sales %87.7-108.1 -81.1%  
Current ratio x3.00.3 886.8%  
Inventory Days Days6895 71.5%  
Debtors Days Days3034 89.7%  
Net fixed assets Rs m8,86229,440 30.1%   
Share capital Rs m458705 64.9%   
"Free" reserves Rs m29,6562,043 1,451.9%   
Net worth Rs m30,1133,800 792.5%   
Long term debt Rs m259,018 0.3%   
Total assets Rs m39,40046,510 84.7%  
Interest coverage x91.5-0.2 -47,391.6%   
Debt to equity ratio x02.4 0.0%  
Sales to assets ratio x0.50.4 126.2%   
Return on assets %11.1-0.8 -1,457.1%  
Return on equity %14.2-146.9 -9.7%  
Return on capital %22.1-3.7 -592.8%  
Exports to sales %037.9 0.0%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs mNA7,378 0.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m4287,513 5.7%   
Fx outflow Rs m7865,649 13.9%   
Net fx Rs m-3581,865 -19.2%   
CASH FLOW
From Operations Rs m9781,682 58.2%  
From Investments Rs m351-9,860 -3.6%  
From Financial Activity Rs m-1,0996,644 -16.5%  
Net Cashflow Rs m231-1,535 -15.0%  

Share Holding

Indian Promoters % 0.0 32.3 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 4.6 163.0%  
FIIs % 4.9 3.3 148.5%  
ADR/GDR % 0.0 4.6 -  
Free float % 23.7 55.3 42.9%  
Shareholders   85,207 84,811 100.5%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   GLENMARK PHARMA  FULFORD INDIA  DR. REDDYS LAB  DIVIS LABORATORIES  UNICHEM LAB  

Compare PFIZER With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Nov 11, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS